Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutant CHCHD10 causes an extensive metabolic rewiring that precedes OXPHOS dysfunction in a murine model of mitochondrial cardiomyopathy
Nicole M. Sayles, Nneka Southwell, Kevin McAvoy, et al.
Cell Reports (2022) Vol. 38, Iss. 10, pp. 110475-110475
Open Access | Times Cited: 21

Showing 21 citing articles:

Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis
Emmanuelle C. Genin, Mélanie Abou-Ali, Véronique Paquis‐Flucklinger
Genes (2023) Vol. 14, Iss. 11, pp. 1981-1981
Open Access | Times Cited: 20
High fat diet ameliorates mitochondrial cardiomyopathy in CHCHD10 mutant mice
Nneka Southwell, Onorina L. Manzo, Sandra R. Bacman, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 6, pp. 1352-1378
Open Access | Times Cited: 4
Coenzyme Q10 deficiency disrupts lipid metabolism by altering cholesterol homeostasis in neurons
Alba Pesini, Eliana Barriocanal‐Casado, Giacomo Monzio Compagnoni, et al.
Free Radical Biology and Medicine (2025) Vol. 229, pp. 441-457
Open Access
NADH-bound AIF activates the mitochondrial CHCHD4/MIA40 chaperone by a substrate-mimicry mechanism
Chris A. Brosey, Runze Shen, John A. Tainer
The EMBO Journal (2025)
Open Access
Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson’s disease models
Ge Gao, Yongyong Shi, Han‐Xiang Deng, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic Management
Jinjuan Yang, Shaoxiang Chen, Fuyu Duan, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3511-3511
Open Access | Times Cited: 16
Mitochondrial Unfolded Protein Response and Integrated Stress Response as Promising Therapeutic Targets for Mitochondrial Diseases
Hedong Lu, Xiaolei Wang, Min Li, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 20-20
Open Access | Times Cited: 16
Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10–what distinguishes the two?
Aya Ikeda, Yuzuru Imai, Nobutaka Hattori
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 14
Loss of mitochondrial Chchd10 or Chchd2 in zebrafish leads to an ALS‐like phenotype and Complex I deficiency independent of the mitochondrial integrated stress response
Virginie Petel Légaré, Christian J. Rampal, Tyler J. N. Gurberg, et al.
Developmental Neurobiology (2023) Vol. 83, Iss. 1-2, pp. 54-69
Open Access | Times Cited: 6
Comparative multi-omic analyses of cardiac mitochondrial stress in three mouse models of frataxin deficiency
Nicole M. Sayles, Jill S. Napierala, Josef Anrather, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 10
Open Access | Times Cited: 6
CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca2+ homeostasis
Aya Ikeda, Hongrui Meng, Daisuke Taniguchi, et al.
PNAS Nexus (2024) Vol. 3, Iss. 8
Open Access | Times Cited: 1
Disease models of mitochondrial aminoacyl‐tRNA synthetase defects
Henna Tyynismaa
Journal of Inherited Metabolic Disease (2023) Vol. 46, Iss. 5, pp. 817-823
Open Access | Times Cited: 3
How to treat a “sweetheart” in mitochondrial cardiomyopathy
Hsin-Pin Lin, Derek P. Narendra
EMBO Molecular Medicine (2024) Vol. 16, Iss. 6, pp. 1226-1227
Open Access
Differential physical interactions of wild-type and S59L mutant CHCHD10 with mitochondrial proteases
Seungjae Oh, Nam Chul Kim
F1000Research (2024) Vol. 13, pp. 731-731
Open Access
CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism
Szu-Chi Liao, Kohei Kano, Sadhna Phanse, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Long-term therapeutic efficacy and safety profiles of hpCas13d RNA editing in treating early-onset hypertrophic cardiomyopathy
Yingmei Lou, Ping Yang, Yuze Wang, et al.
Life Sciences (2024) Vol. 358, pp. 123144-123144
Open Access
Multiomics study ofCHCHD10S59L-related disease reveals energy metabolism downregulation: OXPHOS and β-oxidation deficiencies associated with lipids alterations
Blandine Madji Hounoum, Rachel Bellon, Emmanuelle C. Genin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Comparative multi-omics analyses of cardiac mitochondrial stress in three mouse models of frataxin deficiency
Nicole M. Sayles, Jill S. Napierala, Josef Anrather, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
High fat diet ameliorates the mitochondrial cardiomyopathy of CHCHD10 mutant mice
Nneka Southwell, Onorina L. Manzo, Dazhi Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Mitochondria and Energy Metabolism in the Pathogenesis and Therapy of Amyotrophic Lateral Sclerosis
Csaba Konràd, Giovanni Manfredi
Oxford University Press eBooks (2023)
Closed Access
Loss of mitochondrial Chchd10 or Chchd2 in zebrafish leads to an ALS-like phenotype and Complex I deficiency independent of the mt-ISR
Virginie Petel Légaré, Christian J. Rampal, Mari J. Aaltonen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top